BlackRock Inc. raised its holdings in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 0.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,269,268 shares of the medical instruments supplier’s stock after acquiring an additional 99,455 shares during the quarter. BlackRock Inc. owned approximately 6.28% of DENTSPLY SIRONA worth $717,889,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently made changes to their positions in the company. NuWave Investment Management LLC bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth about $121,000. Focused Wealth Management Inc increased its holdings in shares of DENTSPLY SIRONA by 79.2% in the 4th quarter. Focused Wealth Management Inc now owns 2,600 shares of the medical instruments supplier’s stock worth $171,000 after buying an additional 1,149 shares during the last quarter. Capital One National Association bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth about $204,000. Boston Common Asset Management LLC bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth about $212,000. Finally, Dupont Capital Management Corp increased its holdings in shares of DENTSPLY SIRONA by 85.0% in the 4th quarter. Dupont Capital Management Corp now owns 3,308 shares of the medical instruments supplier’s stock worth $218,000 after buying an additional 1,520 shares during the last quarter. Hedge funds and other institutional investors own 93.80% of the company’s stock.
Shares of XRAY stock traded up $0.34 during trading hours on Friday, hitting $44.91. The company’s stock had a trading volume of 132,916 shares, compared to its average volume of 2,885,995. The company has a market capitalization of $10.26 billion, a P/E ratio of 16.92, a price-to-earnings-growth ratio of 2.34 and a beta of 1.23. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.23 and a quick ratio of 1.46. DENTSPLY SIRONA Inc has a 12-month low of $41.64 and a 12-month high of $68.98.
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 13th. Stockholders of record on Friday, June 29th will be given a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date of this dividend is Thursday, June 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 13.16%.
A number of equities analysts recently commented on XRAY shares. BidaskClub lowered shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a report on Wednesday, February 28th. Credit Suisse Group reduced their price target on shares of DENTSPLY SIRONA from $73.00 to $69.00 and set an “outperform” rating for the company in a report on Friday, March 2nd. HC Wainwright set a $63.00 price target on shares of DENTSPLY SIRONA and gave the company a “hold” rating in a report on Monday, March 5th. Barrington Research reiterated an “outperform” rating and set a $70.00 price objective (down previously from $73.00) on shares of DENTSPLY SIRONA in a research note on Monday, March 5th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of DENTSPLY SIRONA from $75.00 to $70.00 and set an “overweight” rating for the company in a research note on Monday, March 5th. Two analysts have rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $62.23.
In other news, CEO Donald M. Jr. Casey acquired 22,500 shares of the business’s stock in a transaction that occurred on Wednesday, May 9th. The stock was purchased at an average cost of $44.52 per share, for a total transaction of $1,001,700.00. Following the completion of the transaction, the chief executive officer now owns 92,408 shares in the company, valued at $4,114,004.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michael J. Coleman sold 6,038 shares of the firm’s stock in a transaction dated Friday, June 1st. The stock was sold at an average price of $43.97, for a total transaction of $265,490.86. Following the sale, the director now owns 26,960 shares of the company’s stock, valued at $1,185,431.20. The disclosure for this sale can be found here. Insiders sold 7,856 shares of company stock valued at $349,153 over the last quarter. Company insiders own 1.93% of the company’s stock.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.